The following are the stocks scheduled for February, with regulatory catalysts.1. Adamas Pharmaceuticals Inc. (ADMS)The FDA decision on the expanded use of Adamas Pharma's lead drug GOCOVRI is expected on February 1, 2021.GOCOVRI received its initial approval in August 2017 for the treatment of dyskinesia in patients with Parkinson's disease who receives levodopa-based therapy, with or without con...
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.